Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virginia Mason Franciscan Health is a leading integrated healthcare system based in the Pacific Northwest, formed through the 2021 merger of Virginia Mason Health System and CHI Franciscan. The organization is globally recognized for the Virginia Mason Production System (VMPS), a management methodology derived from Lean manufacturing principles to improve healthcare quality and patient safety. Its research arm, the Benaroya Research Institute (BRI), is an international leader in autoimmune disease research, conducting extensive clinical trials and basic science research into conditions like type 1 diabetes and multiple sclerosis. Operating 10 hospitals and nearly 300 care sites, the system provides a comprehensive range of medical services from primary care to advanced specialty treatments. Virginia Mason Franciscan Health is a part of CommonSpirit Health, one of the largest non-profit health systems in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virginia Mason University.